Medication info
Enticsa 10mg (Memantine Hydrochloride)

Enticsa 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Selbion Co., Ltd.
Appearance
Pale yellow to yellow oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907050 · Approved 2019.10.04 · Insurance code 055800320,623006020

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily and should be taken at the same time every day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adult dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1~7): Administer 5mg daily for 7 days. Week 2 (Day 8~14): Administer 10mg daily for 7 days. Week 3 (Day 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule at least 7 days after administration. In patients with severe renal impairment (creatinine clearance 5-29mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Selbion Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily and should be taken at the same time every day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. Adult dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Day 1~7): Administer 5mg daily for 7 days. Week 2 (Day 8~14): Administer 10mg daily for 7 days. Week 3 (Day 15~21): Administer 15mg daily for 7 days. From Week 4 onward: Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg daily. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule at least 7 days after administration. In patients with severe renal impairment (creatinine clearance 5-29mL/min), the daily dose should be reduced to 10mg. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients who have an allergy to any of its components. It should also not be administered to patients with very poor liver function or severely impaired kidney function. Patients with a history of seizures or those who are prone to seizures should use this medication cautiously. Co-administration with certain other medications may exacerbate central nervous system side effects, so combination should be avoided. Patients with changes in urine acidity should be carefully observed, as this may affect the excretion of this medication. Patients with heart disease or uncontrolled hypertension should exercise caution when using this medication. During the use of this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if symptoms are severe, consultation with a physician is necessary. Neurological symptoms such as mental confusion, hallucinations, and seizures have also been reported, and any abnormal symptoms should be reported immediately. This medication may interact with other drugs, so if you are taking any other medications, it is essential to inform your healthcare provider. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is recommended to discontinue breastfeeding if nursing. Safety and efficacy have not been established for use in children or adolescents under the age of 18, so it is advisable to avoid its use in this population. In cases of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, so immediate medical attention is required. This medication may affect patients’ concentration and reaction times, so special care is needed when driving or operating machinery. Keep this medication out of the reach of children and avoid transferring it to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucination
  • psychotic reaction
Show 24 more
  • balance disorder
  • gait abnormalities
  • seizure
  • heart failure
  • venous thromboembolism
  • dyspnea
  • vomiting
  • pancreatitis
  • elevated liver function tests
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • double vision
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain the temperature between 1 degree and 30 degrees Celsius at room temperature to preserve its efficacy.

Appearance and packaging

Appearance

Pale yellow to yellow oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.